Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.81 USD | +1.81% | +10.20% | +12.40% |
04-25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.40% | 37.55M | |
+2.59% | 108B | |
+9.68% | 105B | |
-1.95% | 23.46B | |
-13.09% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.92% | 17.19B | |
+6.26% | 13.99B | |
+34.64% | 12.53B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Piper Sandler Downgrades OncoCyte to Neutral From Overweight, Adjusts Price Target to $0.50 From $1